Valued at USD 3.92 billion in 2024, the global Tremfya market is expected to expand at a CAGR of 7.4% over the next decade, driven by increasing demand for targeted immunotherapies and shifting treatment paradigms in chronic inflammatory diseases. The market is highly segmented based on application, formulation, distribution channel, and therapeutic indication, each presenting unique...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek